Roche’s cobas Influenza A/B test receives CLIA waiver
by Staff from Outbreak News Today on (#NC72)
Roche today announced that the U.S. Food and Drug Administration (FDA) has granted CLIA (Clinical Laboratory Improvement Amendments) waiver for the cobas(R) Influenza A/B test for use on the cobas(R) Liat System. It is the first CLIA-waived, real-time polymerase chain reaction (PCR) test to detect influenza A and B in ~20 minutes. Coupled with the ["]
